CDT Anesthesie: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CDT Anesthesie
Largest movements
- Receivables within one year +€222,500
up €222,500 (+62,078%), from €358 to €222,859
of which Other amounts receivable: +€123,285
- Cash +€73,907
up €73,907 (+83.0%), from €89,034 to €162,942
mainly Net result for the year (+€262,829) and Deferred charges and accrued income (+€36,074)
- Deferred charges and accrued income -€36,074
down €36,074 (-95.6%), from €37,724 to €1,650
- Reserves +€262,829
up €262,829 (+128%), from €204,546 to €467,374
- Gross operating margin +€176,309
up €176,309 (+104%), from €169,021 to €345,330
- Taxes +€44,878
up €44,878 (+113%), from €39,642 to €84,519
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €213,470 | €474,284 | +€260,814 | +122% |
| Fixed assets | 21/28 | €86,354 | €86,834 | +€480 | +0.6% |
| Tangible fixed assets | 22/27 | €86,354 | €86,834 | +€480 | +0.6% |
| Land and buildings | 22 | €83,250 | €83,250 | = | 0.0% |
| Furniture and vehicles | 24 | €3,104 | €3,584 | +€480 | +15.5% |
| Current assets | 29/58 | €127,116 | €387,450 | +€260,334 | +205% |
| Amounts receivable within one year | 40/41 | €358 | €222,859 | +€222,500 | +62,078% |
| Trade receivables | 40 | - | €99,216 | +€99,216 | |
| Other amounts receivable | 41 | €358 | €123,643 | +€123,285 | +34,397% |
| Cash at bank and in hand | 54/58 | €89,034 | €162,942 | +€73,907 | +83.0% |
| Deferred charges and accrued income | 490/1 | €37,724 | €1,650 | -€36,074 | -95.6% |
| Total equity and liabilities | 10/49 | €213,470 | €474,284 | +€260,814 | +122% |
| Equity | 10/15 | €209,546 | €472,374 | +€262,829 | +125% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Reserves | 13 | €204,546 | €467,374 | +€262,829 | +128% |
| Distributable reserves | 133 | €204,546 | €467,374 | +€262,829 | +128% |
| Amounts payable | 17/49 | €3,925 | €1,910 | -€2,015 | -51.3% |
| Amounts payable within one year | 42/48 | €3,925 | €1,910 | -€2,015 | -51.3% |
| Trade debts | 44 | €3,925 | €1,147 | -€2,778 | -70.8% |
| Suppliers | 440/4 | €3,925 | €1,147 | -€2,778 | -70.8% |
| Taxes, remuneration and social security | 45 | - | €763 | +€763 | |
| Taxes | 450/3 | - | €763 | +€763 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €783 | €969 | +€186 | +23.7% |
| Other operating charges | 640/8 | €1,825 | €332 | -€1,492 | -81.8% |
| Gross operating margin | 9900 | €169,021 | €345,330 | +€176,309 | +104% |
| Operating profit (loss) | 9901 | €166,413 | €344,029 | +€177,616 | +107% |
| Financial income | 75/76B | - | €3,364 | +€3,364 | |
| Recurring financial income | 75 | - | €3,364 | +€3,364 | |
| Financial charges | 65/66B | €44 | €45 | +€1 | +3.4% |
| Recurring financial charges | 65 | €44 | €45 | +€1 | +3.4% |
| Profit (loss) for the period before taxes | 9903 | €166,370 | €347,348 | +€180,978 | +109% |
| Income taxes | 67/77 | €39,642 | €84,519 | +€44,878 | +113% |
| Profit (loss) for the period | 9904 | €126,728 | €262,829 | +€136,100 | +107% |
| Profit (loss) for the period to be appropriated | 9905 | €126,728 | €262,829 | +€136,100 | +107% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 21 October 2026 via checked.be.